Qingyu Wang

HLX22 plus trastuzumab and XELOX for first-line treatment of HER2-positive locally advanced or metastatic gastric/gastroesophageal junction cancer (G/GEJC): Updated results with additional patients.

A novel concealed posterior axillary approach for scapula glenoid fractures – a multicenter clinical study

Updated results of HLX22 plus trastuzumab and XELOX for first-line treatment of human epidermal growth factor receptor 2 (HER2)–positive locally advanced or metastatic gastric/gastroesophageal junction cancer (G/GEJC).

Regional homogeneity differences between the brains of young men and young women: A resting-state functional magnetic resonance imaging study

A randomized phase 2 study of HLX22 plus trastuzumab biosimilar HLX02 and XELOX as first-line therapy for HER2-positive advanced gastric cancer

Upregulation of ROBO3 promotes proliferation, migration and adhesion of AML cells and affects the survival of AML patients

LipoxinA4 analog BML-111 protects podocytes cultured in high-glucose medium against oxidative injury via activating Nrf2 pathway

Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study

Corrigendum to “BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells”[Immunology Letters 230 (2021) 27–35]

Adropin and Irisin Deficiencies Are Associated With Presence of Diagonal Earlobe Crease in CAD Patients

BML-111, the lipoxin A4 agonist, modulates VEGF or CoCl2-induced migration, angiogenesis and permeability in tumor-derived endothelial cells

Potassium supplementation blunts the effects of high salt intake on serum retinol‐binding protein 4 levels in healthy individuals

Effects of a Tripeptide Iron on Iron-Deficiency Anemia in Rats